Mesirow Financial Investment Management’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$489K Hold
2,572
0.01% 369
2026
Q1
$434K Buy
2,572
+438
+21% +$74.9K 0.01% 375
2025
Q4
$360K Sell
2,134
-437
-17% -$71K 0.01% 374
2025
Q3
$371K Hold
2,571
0.01% 407
2025
Q2
$325K Sell
2,571
-3,531
-58% -$433K 0.01% 425
2025
Q1
$781K Buy
6,102
+3,051
+100% +$414K 0.02% 288
2024
Q4
$403K Hold
3,051
0.01% 398
2024
Q3
$444K Buy
3,051
+66
+2% +$9.55K 0.01% 383
2024
Q2
$410K Hold
2,985
0.01% 358
2024
Q1
$410K Hold
2,985
0.01% 375
2023
Q4
$405K Buy
+2,985
New +$364K 0.01% 346

Other funds holding IBB

Mesirow Financial Investment Management's IBB Position: Q2 2026 in Review

Mesirow Financial Investment Management held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 2,572 shares worth $489K. The position accounts for 0.01% of the portfolio, ranked #369.

Mesirow Financial Investment Management first reported a position in IBB in Q4 2023 and has held it in 11 quarters since. The position peaked at $781K in Q1 2025. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Mesirow Financial Investment Management held 2,572 shares of iShares Biotechnology ETF worth $489K as of Q2 2026.
  • Mesirow Financial Investment Management left its iShares Biotechnology ETF share count unchanged in Q2 2026.
  • iShares Biotechnology ETF made up 0.01% of Mesirow Financial Investment Management's portfolio in Q2 2026, its #369 holding.
  • Mesirow Financial Investment Management first reported a position in iShares Biotechnology ETF in Q4 2023 and has held it in 11 quarters since.
  • Mesirow Financial Investment Management's iShares Biotechnology ETF position peaked at $781K in Q1 2025.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Mesirow Financial Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.